Published guidance, NICE advice and quality standards

Showing 641 to 650 of 757

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ivabradine for treating chronic heart failure	TA267	28 November 2012	28 November 2012
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours	TA265	24 October 2012	24 October 2012
Alteplase for treating acute ischaemic stroke	TA264	26 September 2012	26 September 2012
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer	TA263	22 August 2012	22 August 2012
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism	TA261	25 July 2012	25 July 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2	TA257	27 June 2012	27 June 2012
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer	TA258	27 June 2012	27 June 2012
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine	TA260	27 June 2012	27 June 2012
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration	TA155	27 August 2008	1 May 2012
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis	TA254	25 April 2012	25 April 2012